AMED Stock Balance Sheets

Amedisys Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Cash and Cash Eq

Account Payables

Amedisys Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31

assets
current assets:
cash and cash equivalents	337,304,000	284,881,000	303,242,000	245,450,000	149,883,000	108,234,000	126,450,000	78,112,000	95,377,000	49,436,000	40,540,000	17,956,000	26,566,000	67,834,000	42,694,000	124,458,000	91,646,000	77,344,000	81,808,000	112,904,000	177,278,000	174,756,000	30,294,000	20,757,000	13,902,000	10,554,000	20,229,000	14,010,000	25,904,000	120,005,000	86,363,000	66,114,000	59,164,000	48,334,000	30,197,000	8,915,000	9,968,000	7,824,000	27,502,000	57,051,000	33,201,000	3,132,000	8,032,000	5,542,000	11,225,000	2,840,000	17,303,000	43,626,000	30,118,000	7,021,000	14,545,000	39,106,000	37,158,000	48,004,000	29,462,000	28,132,000	148,868,000	120,295,000	128,037,000	116,027,000	81,980,000	34,485,000	45,160,000	898,000	25,648,000	2,847,000	5,664,000	1,660,000	25,236,000	56,190,000	66,592,000	91,341,000	107,483,000	84,221,000	9,855,000	7,957,000	9,476,000	17,231,000	20,750,000	72,063,000	78,917,000	89,679,000	93,181,000	22,279,000	24,338	29,779	10,064	12,801	8,341	4,861
patient accounts receivable	295,521,000	319,639,000	296,075,000	301,050,000	356,909,000	359,359,000	313,373,000	319,580,000	278,785,000	294,122,000	296,785,000	302,470,000	305,413,000	293,579,000	274,961,000	274,570,000	278,216,000	275,632,000	255,145,000	250,777,000	249,030,000	268,551,000	237,596,000	254,703,000	239,674,000	236,437,000	188,972,000	195,030,000	197,592,000	192,936,000																																								96,309,000	86,553,000	75,034,000	67,930,000		81,109,000
prepaid expenses	18,282,000	17,410,000	13,072,000	20,485,000	15,510,000	20,332,000	14,639,000	20,534,000	13,774,000	18,754,000	11,628,000	17,011,000	15,199,000	17,221,000	10,356,000	16,080,000	11,979,000	15,449,000	10,217,000	14,906,000	10,788,000	12,487,000	8,243,000	10,601,000	8,957,000	10,792,000	7,568,000	11,679,000	10,493,000	12,430,000	7,329,000	9,770,000	8,800,000	10,097,000	7,397,000	9,948,000	7,931,000	9,086,000	8,110,000	10,402,000	7,568,000	8,504,000	8,493,000	11,303,000	10,855,000	13,675,000	10,669,000	11,460,000	13,369,000	14,478,000	10,631,000	10,646,000	11,180,000	11,321,000	10,950,000	10,976,000	11,605,000	9,947,000	9,932,000	11,713,000	12,651,000	10,279,000	9,199,000	8,865,000	10,128,000	8,086,000	7,159,000	8,573,000	10,714,000	6,023,000	4,956,000	4,786,000	5,091,000	4,133,000	3,222,000	4,286,000	4,906,000	2,693,000	2,570,000	2,613,000	3,572,000	1,356,000	2,538,000	2,268,000	2,452	1,103	1,428	1,631	1,929	1,600
other current assets	11,091,000	12,034,000	19,694,000	12,962,000	26,125,000	26,053,000	30,060,000	33,097,000	22,824,000	23,581,000	26,415,000	37,839,000	25,493,000	10,776,000	25,598,000	14,024,000	8,124,000	11,025,000	13,265,000	30,114,000	9,395,000	9,278,000	8,225,000	13,458,000	13,252,000	13,948,000	7,349,000	11,949,000	24,784,000	18,148,000	16,268,000	14,904,000	31,789,000	11,964,000	11,260,000	12,070,000	9,407,000	5,959,000	14,641,000	5,641,000	17,147,000	23,556,000	19,708,000	12,577,000	15,185,000	14,309,000	10,785,000	9,819,000	12,006,000	16,229,000	11,440,000	20,635,000	24,801,000	24,630,000	13,795,000	12,400,000	15,701,000	22,139,000	7,838,000	10,776,000	15,905,000	23,003,000	5,539,000	9,154,000	8,727,000	7,719,000	7,872,000	3,903,000	3,858,000	5,991,000	5,847,000	4,683,000	3,887,000	11,125,000	2,824,000	5,912,000	2,366,000	4,277,000
total current assets	662,198,000	633,964,000	632,083,000	579,947,000	555,902,000	526,448,000	496,935,000	467,227,000	426,544,000	405,557,000	388,961,000	388,780,000	394,869,000	392,485,000	356,684,000	432,882,000	390,965,000	380,450,000	361,984,000	411,250,000	449,540,000	468,128,000	350,554,000	299,519,000	275,785,000	271,731,000	224,118,000	232,668,000	258,773,000	343,519,000	311,156,000	268,190,000	273,141,000	243,102,000	214,910,000	193,433,000	179,519,000	176,729,000	175,263,000	216,441,000	168,370,000	145,843,000	135,558,000	142,434,000	158,911,000	203,517,000	205,279,000	234,410,000	181,809,000	182,387,000	205,788,000	233,848,000	236,300,000	232,016,000	205,415,000	204,781,000	318,097,000	293,930,000	282,257,000	290,371,000	261,108,000	218,036,000	200,909,000	173,196,000	198,871,000	194,350,000	200,463,000	177,074,000	183,874,000	164,513,000	169,881,000	181,757,000	190,312,000	179,205,000	97,010,000	81,969,000	84,150,000	92,340,000	92,030,000	114,900,000	110,175,000	118,890,000	115,222,000	45,511,000	43,783	49,596	26,438	26,954	23,669	22,588
property and equipment, net of accumulated depreciation of 104,613 and 100,890	38,273,000
operating lease right of use assets	86,614,000	80,905,000	81,500,000	85,110,000	84,692,000	88,425,000	88,939,000	87,834,000	85,142,000	85,211,000	102,856,000	105,843,000	107,723,000	102,801,000	101,257,000	100,028,000	95,034,000	94,620,000	93,440,000	94,273,000	92,904,000	83,693,000	84,791,000	84,124,000	85,026,000	83,064,000
goodwill	1,213,888,000	1,213,888,000	1,213,888,000	1,244,679,000	1,244,679,000	1,244,679,000	1,244,679,000	1,244,679,000	1,244,679,000	1,244,679,000	1,287,399,000	1,285,455,000	1,289,672,000	1,204,638,000	1,196,090,000	1,188,054,000	936,772,000	933,207,000	932,685,000	931,483,000	937,088,000	721,049,000	658,500,000	660,472,000	664,822,000	649,514,000	329,480,000	324,145,000	324,145,000	322,199,000	319,949,000	313,663,000	313,663,000	292,793,000	288,957,000	284,552,000	280,349,000	285,124,000	261,663,000	211,109,000	205,587,000	205,587,000	205,587,000	205,587,000	205,587,000	208,923,000	208,915,000	208,126,000	209,260,000	209,994,000	209,594,000	367,495,000	343,353,000	334,695,000	335,811,000	901,611,000	791,412,000	791,412,000	790,409,000	790,210,000	789,054,000	786,923,000	765,137,000	749,238,000	736,253,000	733,881,000	701,113,000	697,545,000	734,187,000	332,534,000	307,375,000	249,632,000	219,061,000	213,032,000	210,337,000	207,775,000	201,218,000	197,002,000	194,502,000	85,120,000	80,065,000	62,537,000
intangible assets, net of accumulated amortization of 21,134 and 18,787	79,243,000
other assets	135,169,000	135,432,000	87,980,000	87,680,000	86,609,000	85,857,000	85,097,000	84,412,000	84,894,000	78,230,000	79,836,000	81,123,000	84,686,000	84,639,000	73,023,000	68,105,000	64,103,000	32,913,000	33,200,000	33,278,000	33,673,000	52,287,000	54,612,000	54,260,000	58,288,000	54,888,000	54,145,000	53,406,000	50,601,000	49,856,000	49,130,000	48,976,000	38,320,000	38,894,000	38,468,000	39,741,000	37,875,000	34,914,000	36,172,000	34,259,000	30,845,000	35,051,000	33,161,000	30,199,000	28,898,000	27,589,000	26,283,000	26,501,000	23,932,000	24,855,000	18,650,000	16,963,000	23,606,000	24,322,000	29,190,000	27,478,000	21,780,000	22,536,000	17,536,000	18,764,000	17,750,000	17,865,000	20,512,000	20,988,000	19,746,000	20,317,000	24,280,000	24,719,000	16,401,000	7,450,000	6,871,000	6,725,000	5,600,000	5,826,000	7,147,000	7,037,000	12,444,000	11,819,000	5,777,000	6,042,000	6,188,000	3,856,000					34,331	25,737	25,748
total assets	2,215,385,000	2,184,574,000	2,138,714,000	2,139,114,000	2,117,368,000	2,089,871,000	2,060,170,000	2,027,417,000	1,982,402,000	1,946,959,000	1,976,245,000	1,982,127,000	2,000,986,000	1,908,392,000	1,856,968,000	1,937,645,000	1,599,563,000	1,573,209,000	1,567,198,000	1,602,720,000	1,645,488,000	1,440,084,000	1,262,745,000	1,212,380,000	1,205,862,000	1,184,239,000	717,118,000	725,892,000	753,324,000	842,288,000	813,482,000	799,529,000	805,873,000	756,628,000	734,029,000	721,732,000	711,102,000	705,645,000	685,085,000	666,436,000	645,433,000	623,327,000	669,742,000	682,213,000	710,296,000	727,390,000	726,406,000	754,569,000	700,253,000	712,317,000	730,595,000	875,724,000	858,299,000	858,285,000	846,776,000	1,340,647,000	1,327,560,000	1,299,825,000	1,263,922,000	1,269,220,000	1,222,445,000	1,172,351,000	1,130,940,000	1,083,398,000	1,086,401,000	1,070,194,000	1,050,723,000	1,022,450,000	1,037,747,000	587,111,000	564,727,000	518,671,000	483,115,000	463,756,000	370,188,000	347,680,000	339,511,000	339,997,000	330,605,000	232,919,000	217,726,000	199,733,000	187,914,000	111,015,000	106,128	92,473	67,688	60,069	58,006	58,324
liabilities and equity
current liabilities:
accounts payable	29,789,000	28,705,000	39,956,000	32,117,000	26,626,000	36,249,000	28,237,000	34,555,000	38,557,000	40,017,000	43,735,000	45,527,000	43,509,000	36,621,000	38,217,000	41,649,000	36,668,000	38,865,000	42,674,000	39,037,000	33,383,000	31,147,000	31,259,000	35,901,000	35,690,000	32,797,000	28,531,000	24,519,000	29,810,000	22,966,000	25,384,000	22,815,000	29,119,000	29,444,000	30,358,000	33,088,000	35,070,000	33,627,000	25,682,000	24,226,000	21,911,000	23,651,000	16,056,000	19,363,000	18,886,000	24,198,000	20,139,000	24,362,000	21,658,000	27,646,000	29,175,000	21,690,000	24,425,000	25,475,000	22,347,000	21,843,000	21,290,000	23,374,000	19,551,000	22,968,000	21,554,000	16,535,000	18,999,000	17,391,000	18,528,000	18,652,000	15,535,000	19,681,000	21,520,000	14,438,000	14,370,000	10,533,000	10,916,000	14,339,000	13,643,000	13,527,000	7,919,000	29,922,000	10,170,000	4,521,000	4,419,000	6,681,000	3,674,000	3,255,000	5,009	3,340	2,411	2,029	1,776	2,495
payroll and employee benefits	138,515,000	131,722,000	151,995,000	138,374,000	136,118,000	131,631,000	136,835,000	126,989,000	123,234,000	122,723,000	125,387,000	145,073,000	161,068,000	151,279,000	141,001,000	155,123,000	147,017,000	150,887,000	146,929,000	126,543,000	128,275,000	109,713,000	120,877,000	115,899,000	111,660,000	111,312,000	92,858,000	92,385,000	87,239,000	88,585,000	89,936,000	86,139,000	81,331,000	81,909,000	82,480,000	78,754,000	86,075,000	82,837,000	72,546,000	74,050,000	74,688,000	69,791,000	75,553,000	71,208,000	72,861,000	76,066,000	70,801,000	68,923,000	76,205,000	78,919,000	79,341,000	81,751,000	86,590,000	82,130,000	77,038,000	78,077,000	88,322,000	100,700,000	117,200,000	119,549,000	124,832,000
accrued expenses	150,379,000	162,180,000	152,564,000	145,611,000	147,038,000	147,464,000	140,049,000	139,100,000	137,359,000	137,899,000	137,390,000	130,100,000	176,239,000	148,044,000	150,836,000	154,264,000	166,157,000	170,954,000	166,192,000	170,743,000	169,722,000	136,659,000	137,111,000	127,111,000	131,860,000	121,716,000	99,475,000	101,177,000	96,472,000	88,842,000	89,104,000	83,516,000	62,981,000	65,663,000	63,290,000	65,112,000	63,641,000	63,903,000	71,965,000	69,188,000	64,101,000	56,763,000	56,329,000	53,494,000	61,712,000	61,498,000	57,572,000	54,340,000	54,175,000	57,054,000	54,855,000	64,460,000	62,218,000	68,493,000	67,939,000	70,014,000	69,321,000	36,149,000	33,746,000	36,650,000	35,592,000	152,654,000	158,527,000	144,115,000	128,253,000	134,049,000	121,497,000	111,978,000	95,806,000	66,667,000	66,286,000	58,549,000	53,833,000	46,587,000	53,273,000	51,672,000	49,415,000	45,165,000
termination fee paid by unitedhealth group	106,000,000	106,000,000	106,000,000	106,000,000	106,000,000	106,000,000	106,000,000	106,000,000	106,000,000
current portion of long-term obligations	36,799,000	37,579,000	37,968,000	37,478,000	37,747,000	37,232,000	36,314,000	35,364,000	31,465,000	26,958,000	15,496,000	12,628,000	12,521,000	12,309,000	12,995,000	13,225,000	10,160,000	10,329,000	10,496,000	10,711,000	10,718,000	11,122,000	9,927,000	8,959,000	7,610,000	6,038,000	1,612,000	1,209,000	668,000	10,417,000	10,638,000	9,387,000	8,137,000	6,888,000	5,220,000	5,220,000	5,000,000	20,000,000	5,000,000	3,750,000	12,000,000	12,000,000	12,000,000	12,000,000	12,277,000	12,952,000	13,904,000	34,855,000	35,807,000	35,807,000	35,807,000	54,307,000	60,700,000	33,888,000	33,525,000	35,448,000	36,101,000	37,178,000	39,265,000	41,773,000	40,581,000	44,254,000	43,779,000	44,795,000	42,451,000	42,632,000	43,716,000	42,739,000	41,496,000	11,049,000	10,356,000	7,237,000	3,779,000	3,223,000	11,416,000	11,194,000	9,881,000
current portion of operating lease liabilities	26,879,000	25,845,000	25,909,000	26,441,000	26,447,000	26,284,000	26,286,000	26,111,000	25,786,000	25,453,000	33,521,000	33,872,000	34,035,000	31,901,000	31,233,000	31,553,000	30,893,000	30,047,000	30,046,000	30,462,000	29,950,000	27,465,000	27,769,000	26,783,000	26,187,000	25,514,000
total current liabilities	488,361,000	492,031,000	514,392,000	486,021,000	479,976,000	484,860,000	473,721,000	468,119,000	462,401,000	353,050,000	355,529,000	367,200,000	427,372,000	380,154,000	374,282,000	454,349,000	449,223,000	456,082,000	456,337,000	437,496,000	442,048,000	316,106,000	326,943,000	314,653,000	313,007,000	297,377,000	222,476,000	219,290,000	214,189,000	210,810,000	215,062,000	201,857,000	225,318,000	183,904,000	181,348,000	182,174,000	189,786,000	200,367,000	175,193,000	171,214,000	176,029,000	164,234,000	162,323,000	191,065,000	200,736,000	324,714,000	312,416,000	332,480,000	191,014,000	202,821,000	204,787,000	231,457,000	245,004,000	221,734,000	209,508,000	215,790,000	227,728,000	216,304,000	218,627,000	238,237,000	238,623,000	229,306,000	232,584,000	217,263,000	197,316,000	204,627,000	192,908,000	179,029,000	173,162,000	101,736,000	107,167,000	91,484,000	82,735,000	81,918,000	92,124,000	88,739,000	90,941,000	99,955,000	87,115,000	52,425,000	48,136,000	41,976,000	40,004,000	40,574,000	41,873	34,018	33,031	31,056	30,547	31,120
long-term obligations, less current portion	326,425,000	332,947,000	339,313,000	344,428,000	351,442,000	356,080,000	361,862,000	366,853,000	369,896,000	373,202,000	419,420,000	443,431,000	442,413,000	429,453,000	432,075,000	434,781,000	179,415,000	231,380,000	204,511,000	300,576,000	392,713,000	379,942,000	232,256,000	231,641,000	266,468,000	303,733,000	5,775,000	54,853,000	123,937,000	75,782,000	78,203,000	80,523,000	83,157,000	85,472,000	87,809,000	88,874,000	89,500,000	90,565,000	95,000,000	96,250,000	83,517,000	86,444,000	104,372,000	102,299,000	132,000,000	30,000,000	33,000,000	36,000,000	39,000,000	42,952,000	66,904,000	67,856,000	67,701,000	111,551,000	119,726,000	127,901,000	136,138,000	144,688,000	153,414,000	162,349,000	162,799,000	170,899,000	179,440,000	196,904,000	268,407,000	285,942,000	316,015,000	336,458,000	375,932,000	12,991,000	13,325,000	8,064,000		2,114,000
operating lease liabilities, less current portion	60,404,000	55,642,000	56,111,000	59,323,000	59,007,000	62,220,000	62,751,000	61,878,000	59,634,000	59,826,000	69,504,000	72,030,000	72,619,000	70,295,000	69,309,000	67,723,000	63,152,000	63,359,000	61,987,000	62,519,000	61,611,000	54,926,000	56,128,000	56,619,000	57,392,000	55,840,000
deferred income tax liabilities	64,445,000	58,032,000	48,051,000	48,017,000	47,212,000	43,229,000	40,635,000	35,398,000	28,085,000	22,752,000	20,411,000	15,983,000	6,179,000	2,915,000
other long-term obligations	847,000	848,000	882,000	886,000	845,000	828,000	1,418,000	1,651,000	1,629,000	4,781,000	4,808,000	13,873,000	13,408,000	4,923,000	4,979,000	31,991,000	31,886,000	32,814,000	33,622,000	44,386,000	26,857,000	8,966,000	5,905,000	6,002,000	6,053,000	6,089,000	6,234,000	6,253,000	6,137,000	6,138,000	3,791,000	3,930,000	4,337,000	4,306,000	3,730,000	4,306,000	3,991,000	3,934,000	4,456,000	4,998,000	5,837,000	5,214,000	5,285,000	5,748,000	6,518,000	9,761,000	8,511,000	8,297,000	5,209,000	4,761,000	4,671,000	4,431,000	4,274,000	4,852,000	5,561,000	5,460,000	5,291,000	6,832,000	6,963,000	7,074,000	5,787,000	6,412,000	8,654,000	8,482,000	5,791,000	5,959,000	6,882,000	7,296,000	6,086,000	6,069,000	6,036,000	6,841,000	5,785,000	4,936,000	1,298,000	1,184,000	1,062,000
total liabilities	940,482,000	939,500,000	958,749,000	938,675,000	938,482,000	947,217,000	940,387,000	933,899,000	921,645,000	813,611,000	869,672,000	912,517,000	961,991,000	887,740,000	880,645,000	988,844,000	723,676,000	783,635,000	756,457,000	844,977,000	923,229,000	759,940,000	621,232,000	608,915,000	642,920,000	663,039,000	234,485,000	280,396,000	344,263,000	292,730,000	297,056,000	286,310,000	312,812,000	273,682,000	272,887,000	275,354,000	283,277,000	294,866,000	274,649,000	272,462,000	265,383,000	255,892,000	271,980,000	299,112,000	339,254,000	364,475,000	353,927,000	376,777,000	235,223,000	250,534,000	276,362,000	303,744,000	316,979,000	338,137,000	334,795,000	410,667,000	423,433,000	420,110,000	415,701,000	441,699,000	438,030,000	436,016,000	444,792,000	440,556,000	488,299,000	508,076,000	521,657,000	525,685,000	568,509,000	139,291,000	139,749,000	119,228,000	103,132,000	99,749,000	138,434,000	131,820,000	136,575,000	147,398,000	148,159,000	63,349,000	58,928,000	51,260,000	46,924,000	46,919,000	48,548	41,074	42,312	38,930	38,909	41,361
commitments and contingencies—note 7
equity:
preferred stock, 0.001 par value, 5,000,000 shares authorized; none issued or outstanding
common stock	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	38,000	37,000	37,000	37,000	37,000	37,000	36,000	36,000	36,000	36,000	36,000	35,000	35,000	36,000	36,000	35,000	35,000	35,000	35,000	35,000	35,000	35,000	35,000	35,000	35,000	34,000	34,000	33,000	33,000	33,000	33,000	32,000	32,000	32,000	31,000	30,000	30,000	30,000	30,000	29,000	29,000	29,000	29,000	28,000	28,000	28,000	27,000	27,000	27,000	27,000	27,000	26,000	26,000	26,000	26,000	26,000	16,000	16,000	16,000	16,000	16,000	16,000	15,000	15,000	15,000	12,000		12	10	10		9
additional paid-in capital	833,099,000	825,138,000	818,201,000	809,655,000	803,361,000	795,063,000	787,177,000	776,880,000	768,789,000	758,669,000	755,063,000	750,914,000	743,276,000	736,536,000	728,118,000	720,875,000	714,334,000	707,006,000	698,287,000	690,099,000	665,580,000	656,266,000	645,256,000	634,854,000	623,309,000	613,714,000	603,666,000	592,539,000	585,137,000	575,926,000	568,780,000	561,380,000	555,029,000	544,428,000	537,472,000	531,112,000	523,583,000	510,881,000	504,290,000	495,827,000	490,474,000	486,267,000	481,762,000	477,115,000	473,634,000	470,851,000	467,890,000	462,962,000	458,475,000	456,046,000	450,792,000	446,233,000	441,479,000	432,390,000	428,400,000	422,273,000	416,425,000	407,156,000	398,133,000	387,377,000	374,981,000	363,670,000	351,582,000	344,446,000	335,111,000	326,120,000	318,957,000	310,017,000	302,871,000	297,802,000	291,706,000	287,199,000	282,638,000	279,553,000	158,342,000	153,007,000	149,109,000	146,684,000	143,959,000	138,751,000	135,696,000	132,032,000	130,685,000	58,980,000	57,425	55,465	32,807	30,951	30,424	29,439
treasury stock	-480,859,000	-477,718,000	-474,854,000	-473,466,000	-472,821,000	-469,243,000	-468,626,000	-465,613,000	-464,688,000	-462,508,000	-461,200,000	-461,168,000	-457,981,000	-440,550,000	-435,868,000	-420,665,000	-400,110,000	-398,752,000	-319,092,000	-318,771,000	-257,625,000	-255,291,000	-251,241,000	-251,070,000	-246,175,000	-244,373,000	-241,685,000	-240,536,000	-237,947,000	-55,019,000	-53,713,000	-53,228,000	-52,500,000	-47,531,000	-46,774,000	-46,253,000	-45,829,000	-39,529,000	-26,966,000	-22,029,000	-22,026,000	-19,860,000	-19,860,000	-19,483,000	-19,464,000	-18,191,000	-18,176,000	-18,080,000	-18,056,000	-17,119,000	-17,116,000	-17,034,000	-17,014,000	-15,770,000	-15,762,000	-15,702,000	-14,194,000	-14,022,000	-14,008,000	-2,156,000	-791,000	-735,000	-735,000	-681,000	-649,000	-617,000	-515,000	-516,000	-437,000	-437,000	-437,000	-437,000	-403,000	-379,000	-52,000	-52,000	-25,000	-25,000	-25,000	-25,000	-25,000	-25,000	-25,000	-25,000	-25	-25	-25	-25	-25	-25
retained earnings	880,252,000	852,168,000	791,156,000	811,537,000	794,626,000	762,325,000	747,925,000	728,603,000	702,643,000	782,918,000	757,672,000	725,955,000	700,313,000	670,734,000	639,063,000	605,016,000	560,010,000	479,861,000	429,991,000	384,840,000	312,859,000	278,185,000	246,383,000	218,728,000	184,596,000	150,854,000	119,550,000	92,089,000	60,712,000	27,363,000	204,000	4,053,000		-14,967,000	-30,545,000	-39,462,000	-50,897,000	-61,593,000	-67,806,000	-80,717,000	-89,157,000	-99,794,000	-64,785,000	-73,920,000	-82,359,000	-89,978,000	-77,561,000	-67,932,000	23,136,000	21,296,000	18,617,000	125,429,000	115,507,000	102,205,000	97,891,000	521,612,000	499,957,000	484,669,000	462,571,000	440,937,000	408,735,000	372,089,000	334,296,000	298,357,000	263,274,000	236,252,000	209,911,000	186,418,000	166,034,000	149,570,000	132,855,000	112,639,000	97,722,000	84,807,000	73,448,000	62,889,000	53,836,000	46,552,000	39,251,000	31,491,000	23,561,000	16,451,000	10,315,000	5,129,000	168				-11,311	-12,460
total amedisys, inc. stockholders’ equity	1,232,530,000	1,199,626,000	1,134,541,000	1,147,764,000	1,125,204,000	1,088,183,000	1,066,514,000	1,039,908,000	1,006,782,000	1,079,117,000	1,051,573,000	1,015,739,000	985,646,000	966,758,000	931,351,000	905,264,000	874,272,000	788,153,000	809,224,000	756,205,000	720,851,000	679,197,000	640,450,000	602,564,000	561,781,000	520,246,000	481,582,000	444,143,000	407,953,000	548,320,000	515,321,000	512,256,000	492,075,000	481,980,000	460,203,000	445,447,000	426,907,000	409,809,000	409,568,000	393,131,000	379,341,000	366,663,000	397,167,000	383,761,000	371,860,000	362,730,000	372,201,000	376,998,000	463,603,000	460,270,000	452,340,000	554,675,000	540,018,000	518,868,000		928,228,000	902,233,000	877,857,000	846,715,000	826,189,000	783,062,000	735,166,000	685,135,000	641,969,000
noncontrolling interests	42,373,000	45,448,000	45,424,000	52,675,000	53,682,000	54,471,000	53,269,000	53,610,000	53,975,000	54,231,000	55,000,000	53,871,000	53,349,000	53,894,000	44,972,000	43,537,000	1,615,000	1,421,000	1,517,000	1,538,000	1,408,000	947,000	1,063,000	901,000	1,161,000	954,000	1,051,000	1,353,000	1,108,000	1,238,000	1,105,000	963,000	986,000	966,000	939,000	931,000	918,000	970,000	868,000	843,000	709,000	772,000	595,000	-660,000	-818,000	185,000	278,000	794,000	1,427,000	1,513,000	1,893,000	17,305,000	1,302,000	1,280,000	1,407,000	1,752,000	1,894,000	1,858,000	1,506,000	1,332,000	1,353,000	1,169,000	1,013,000	873,000	808,000
total equity	1,274,903,000	1,245,074,000	1,179,965,000	1,200,439,000	1,178,886,000	1,142,654,000	1,119,783,000	1,093,518,000	1,060,757,000	1,133,348,000	1,106,573,000	1,069,610,000	1,038,995,000	1,020,652,000	976,323,000	948,801,000	875,887,000	789,574,000	810,741,000	757,743,000	722,259,000	680,144,000	641,513,000	603,465,000	562,942,000	521,200,000	482,633,000	445,496,000	409,061,000	549,558,000	516,426,000	513,219,000	493,061,000	482,946,000	461,142,000	446,378,000	427,825,000	410,779,000	410,436,000	393,974,000	380,050,000	367,435,000	397,762,000	383,101,000	371,042,000	362,915,000	372,479,000	377,792,000	465,030,000	461,783,000	454,233,000	571,980,000	541,320,000	520,148,000	511,981,000	929,980,000	904,127,000	879,715,000	848,221,000	827,521,000	784,415,000	736,335,000	686,148,000	642,842,000	598,102,000
total liabilities and equity	2,215,385,000	2,184,574,000	2,138,714,000	2,139,114,000	2,117,368,000	2,089,871,000	2,060,170,000	2,027,417,000	1,982,402,000	1,946,959,000	1,976,245,000	1,982,127,000	2,000,986,000	1,908,392,000	1,856,968,000	1,937,645,000	1,599,563,000	1,573,209,000	1,567,198,000	1,602,720,000	1,645,488,000	1,440,084,000	1,262,745,000	1,212,380,000	1,205,862,000	1,184,239,000	717,118,000	725,892,000	753,324,000	842,288,000	813,482,000	799,529,000	805,873,000	756,628,000	734,029,000	721,732,000	711,102,000	705,645,000	685,085,000	666,436,000	645,433,000	623,327,000	669,742,000	682,213,000	710,296,000	727,390,000	726,406,000	754,569,000	700,253,000	712,317,000	730,595,000	875,724,000	858,299,000	858,285,000	846,776,000	1,340,647,000	1,327,560,000	1,299,825,000	1,263,922,000	1,269,220,000	1,222,445,000	1,172,351,000	1,130,940,000	1,083,398,000	1,086,401,000
property and equipment, net of accumulated depreciation of 103,758 and 100,890		40,186,000
intangible assets, net of accumulated amortization of 19,949 and 18,787		80,199,000
restricted cash					7,475,000	12,470,000	12,413,000	15,904,000	15,784,000	19,664,000	13,593,000	13,504,000	22,198,000	3,075,000	3,075,000	3,750,000	1,000,000	1,000,000	1,549,000	2,549,000	3,049,000	3,056,000	66,196,000																																																5,933,000	5,913,000	5,921,000	4,797,000
property and equipment, net of accumulated depreciation of 100,890 and 92,422			42,108,000
intangible assets, net of accumulated amortization of 18,787 and 14,008			81,155,000
commitments and contingencies – note 11
property and equipment, net of accumulated depreciation of 101,003 and 92,422				42,000,000
intangible assets, net of accumulated amortization of 17,603 and 14,008				99,698,000
property and equipment, net of accumulated depreciation of 98,850 and 92,422					44,654,000
intangible assets, net of accumulated amortization of 16,259 and 14,008					100,832,000
property and equipment, net of accumulated depreciation of 96,056 and 92,422						42,684,000
intangible assets, net of accumulated amortization of 15,128 and 14,008						101,778,000
property and equipment, net of accumulated depreciation of 92,422 and 101,364							41,845,000
intangible assets, net of accumulated amortization of 14,008 and 14,604							102,675,000
commitments and contingencies – note 12
property and equipment, net of accumulated depreciation of 93,909 and 101,364								39,631,000
intangible assets, net of accumulated amortization of 12,838 and 14,604								103,634,000
commitments and contingencies—note 6
property and equipment, net of accumulated depreciation of 90,523 and 101,364									36,399,000
intangible assets, net of accumulated amortization of 17,714 and 14,604									104,744,000
property and equipment, net of accumulated depreciation of 105,183 and 101,364										33,353,000
intangible assets, net of accumulated amortization of 16,071 and 14,604										99,929,000
property and equipment, net of accumulated depreciation of 101,364 and 96,937											16,026,000
intangible assets, net of accumulated amortization of 14,604 and 19,900											101,167,000
deferred income tax assets
property and equipment, net of accumulated depreciation of 102,407 and 96,937												17,248,000
intangible assets, net of accumulated amortization of 11,891 and 19,900												103,678,000
property and equipment, net of accumulated depreciation of 100,265 and 96,937													17,847,000
intangible assets, net of accumulated amortization of 9,109 and 19,900													106,189,000
property and equipment, net of accumulated depreciation of 98,573 and 96,937														17,295,000
intangible assets, net of accumulated amortization of 18,590 and 19,900														106,534,000
property and equipment, net of accumulated depreciation of 96,937 and 95,024															18,435,000
intangible assets, net of accumulated amortization of 19,900 and 22,973															111,190,000
deferred income taxes															289,000	10,111,000	25,271,000	40,576,000	47,987,000	24,189,000	25,463,000	20,199,000	21,427,000	17,568,000	30,213,000	32,525,000	35,794,000	41,149,000	46,919,000	53,119,000	56,064,000	91,160,000	100,806,000	98,943,000	107,940,000	113,797,000	121,014,000	121,367,000	125,245,000	1,953,000	140,485,000	146,565,000		10,153,000	10,712,000	57,325,000	55,329,000	57,008,000								61,516,000	54,276,000	52,286,000	36,697,000	34,039,000	30,821,000	29,399,000	24,114,000	17,907,000	16,785,000	11,548,000	5,852,000	1,074,000	13,329,000	18,495,000	13,221,000	12,839,000	12,057,000	10,781,000	8,499,000	2,680,000	3,421,000	3,556,000	3,671,000	8,008,000	7,711,000				831	1,650	2,424	2,376	2,080	1,803
provider relief fund advance																58,535,000	58,328,000	55,000,000	60,000,000	60,000,000	70,000,000
property and equipment, net of accumulated depreciation of 100,407 and 95,024																20,381,000
intangible assets, net of accumulated amortization of 20,309 and 22,973																118,084,000
property and equipment, net of accumulated depreciation of 98,552 and 95,024																	20,986,000
intangible assets, net of accumulated amortization of 15,842 and 22,973																	66,432,000
property and equipment, net of accumulated depreciation of 97,698 and 95,024																		21,679,000
intangible assets, net of accumulated amortization of 12,738 and 22,973																		69,764,000
property and equipment, net of accumulated depreciation of 95,024 and 96,137																			23,719,000
intangible assets, net of accumulated amortization of 22,973 and 7,044																			74,183,000
accumulated other comprehensive income																							15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	15,000	13,000	15,000	15,000	15,000	25,000	-10,000	2,000	108,000	114,000				-447,000	-92,000	12,000	-62,000	10,000		16,000
property and equipment, net of accumulated depreciation of 101,512 and 96,137																				24,104,000
intangible assets, net of accumulated amortization of 17,165 and 7,044																				84,143,000
commitments and contingencies—note 5
property and equipment, net of accumulated depreciation of 100,963 and 96,137																					25,007,000
intangible assets, net of accumulated amortization of 12,649 and 7,044																					81,813,000
property and equipment, net of accumulated depreciation of 98,472 and 96,137																						26,477,000
intangible assets, net of accumulated amortization of 9,341 and 7,044																						68,251,000
property and equipment, net of accumulated depreciation of 96,137 and 95,472																							28,113,000
intangible assets, net of accumulated amortization of 7,044 and 693																							64,748,000
commitments and contingencies – note 10
property and equipment, net of accumulated depreciation of 101,446 and 95,472																								29,969,000
intangible assets, net of accumulated amortization of 36,799 and 33,050																								66,468,000
property and equipment, net of accumulated depreciation of 98,936 and 95,472																									29,762,000
intangible assets, net of accumulated amortization of 35,402 and 33,050																									61,966,000
property and equipment, net of accumulated depreciation of 96,892 and 95,472																										29,716,000
intangible assets, net of accumulated amortization of 33,166 and 33,050																										62,801,000
property and equipment, net of accumulated depreciation of 95,472 and 146,814																											29,449,000
intangible assets, net of accumulated amortization of 33,050 and 30,610																											44,132,000
commitments and contingencies – note 9
property and equipment, net of accumulated depreciation of 93,432 and 146,814																												30,215,000
intangible assets, net of accumulated amortization of 32,443 and 30,610																												44,309,000
property and equipment, net of accumulated depreciation of 101,128 and 146,814																													27,998,000
intangible assets, net of accumulated amortization of 31,864 and 30,610																													44,888,000
property and equipment, net of accumulated depreciation of 130,877 and 146,814																														28,213,000
intangible assets, net of accumulated amortization of 31,288 and 30,610																														45,382,000
patient accounts receivable, net of allowance for doubtful accounts of 20,866, and 17,716																															201,196,000
property and equipment, net of accumulated depreciation of 146,814 and 138,650																															31,122,000
intangible assets, net of accumulated amortization of 30,610 and 27,864																															46,061,000
patient accounts receivable, net of allowance for doubtful accounts of 19,933 and 17,716																																177,402,000
property and equipment, net of accumulated depreciation of 148,301 and 138,650																																32,695,000
intangible assets, net of accumulated amortization of 29,932 and 27,864																																44,845,000
patient accounts receivable, net of allowance for doubtful accounts of 17,865 and 17,716																																	173,388,000
property and equipment, net of accumulated depreciation of 144,708 and 138,650																																	34,420,000
intangible assets, net of accumulated amortization of 29,254 and 27,864																																	45,523,000
accrued charge related to securities class action lawsuit settlement																																	43,750,000
commitments and contingencies - note 5
retained deficit																																	-10,505,000
patient accounts receivable, net of allowance for doubtful accounts of 19,249 and 17,716																																		172,707,000
property and equipment, net of accumulated depreciation of 142,185 and 138,650																																		36,676,000
intangible assets, net of accumulated amortization of 28,557 and 27,864																																		46,220,000
patient accounts receivable, net of allowance for doubtful accounts of 17,716, and 16,526																																			166,056,000
property and equipment, net of accumulated depreciation of 138,650 and 141,793																																			36,999,000
intangible assets, net of accumulated amortization of 27,864 and 25,386																																			46,755,000
patient accounts receivable, net of allowance for doubtful accounts of 16,710 and 16,526																																				162,500,000
property and equipment, net of accumulated depreciation of 144,055 and 141,793																																				42,960,000
intangible assets, net of accumulated amortization of 27,180 and 25,386																																				47,249,000
patient accounts receivable, net of allowance for doubtful accounts of 15,950 and 16,526																																					152,213,000
property and equipment, net of accumulated depreciation of 139,433 and 141,793																																					44,617,000
intangible assets, net of accumulated amortization of 26,525 and 25,386																																					47,728,000
patient accounts receivable, net of allowance for doubtful accounts of 16,751 and 16,526																																						153,860,000
property and equipment, net of accumulated depreciation of 143,277 and 141,793																																						43,963,000
intangible assets, net of accumulated amortization of 25,885 and 25,386																																						43,548,000
patient accounts receivable, net of allowance for doubtful accounts of 16,526, and 14,317																																							125,010,000
property and equipment, net of accumulated depreciation of 141,793 and 146,438																																							42,695,000
intangible assets, net of accumulated amortization of 25,386 and 25,374																																							44,047,000
current portion of deferred income taxes																																									3,329,000	2,029,000	2,385,000						3,169,000	3,395,000	5,609,000	9,249,000	11,071,000	11,748,000	8,659,000	10,408,000	12,694,000	14,285,000	4,247,000	12,679,000	11,446,000	11,245,000	6,661,000	6,344,000	3,453,000	4,663,000	7,529,000		11,155,000	6,771,000	13,344,000	9,238,000	8,280,000	11,630,000	7,653,000	4,473,000	3,180,000	4,173,000		853,000	863,000	1,353,000
patient accounts receivable, net of allowance for doubtful accounts of 14,753 and 14,317																																								121,744,000
assets held for sale																																								19,650,000						18,000	60,000	1,348,000	1,550,000
property and equipment, net of accumulated depreciation of 140,363 and 146,438																																								41,485,000
intangible assets, net of accumulated amortization of 25,379 and 25,374																																								33,150,000
commitments and contingencies - note 6
patient accounts receivable, net of allowance for doubtful accounts of 14,228, and 14,317																																									110,454,000
property and equipment, net of accumulated depreciation of 149,801 and 146,438																																									66,953,000
intangible assets, net of accumulated amortization of 25,374																																									33,193,000	33,193,000
patient accounts receivable, net of allowance for doubtful accounts of 14,845, and 14,317																																										110,651,000
property and equipment, net of accumulated depreciation of 151,311 and 146,438																																										57,088,000
patient accounts receivable, net of allowance for doubtful accounts of 14,317, and 14,231																																											99,325,000
property and equipment, net of accumulated depreciation of 146,438 and 129,891																																											137,455,000
intangible assets, net of accumulated amortization of 25,374 and 25,133																																											33,193,000
accrued charge related to u.s. department of justice settlement																																												35,000,000	35,000,000	150,000,000	150,000,000	150,000,000
patient accounts receivable, net of allowance for doubtful accounts of 15,640 and 14,231																																												102,859,000
property and equipment, net of accumulated depreciation of 142,066 and 129,891																																												141,419,000
intangible assets, net of accumulated amortization of 25,370 and 25,133																																												34,096,000
patient accounts receivable, net of allowance for doubtful accounts of 14,956 and 14,231																																													110,934,000
property and equipment, net of accumulated depreciation of 140,705 and 129,891																																													148,346,000
intangible assets, net of accumulated amortization of 25,354 and 25,133																																													34,112,000
patient accounts receivable, net of allowance for doubtful accounts of 14,131 and 14,231																																														115,350,000
property and equipment, net of accumulated depreciation of 137,022 and 129,891																																														157,034,000
intangible assets, net of accumulated amortization of 25,279 and 25,133																																														34,336,000
patient accounts receivable, net of allowance for doubtful accounts of 14,231, and 20,994																																															111,133,000
property and equipment, net of accumulated depreciation of 129,891 and 113,154																																															159,025,000
intangible assets, net of accumulated amortization of 25,133 and 23,457																																															36,690,000
patient accounts receivable, net of allowance for doubtful accounts of 15,601 and 20,994																																																111,149,000
property and equipment, net of accumulated depreciation of 125,392 and 113,154																																																160,077,000
intangible assets, net of accumulated amortization of 24,926 and 23,457																																																42,332,000
deferred tax asset																																																83,123,000	85,256,000	91,808,000	92,804,000	54,512,000	59,498,000	68,649,000	77,173,000
patient accounts receivable, net of allowance for doubtful accounts of 17,610 and 20,994																																																	124,766,000
property and equipment, net of accumulated depreciation of 120,012 and 113,154																																																	156,887,000
intangible assets, net of accumulated amortization of 24,560 and 23,457																																																	43,109,000
patient accounts receivable, net of allowance for doubtful accounts of 18,991, and 20,994																																																		144,659,000
property and equipment, net of accumulated depreciation of 118,280 and 113,154																																																		156,481,000
intangible assets, net of accumulated amortization of 24,119 and 23,457																																																		46,792,000
commitments and contingencies—note 4
patient accounts receivable, net of allowance for doubtful accounts of 20,994, and 17,438																																																			169,172,000
property and equipment, net of accumulated depreciation of 113,154 and 94,266																																																			156,709,000
intangible assets, net of accumulated amortization of 23,457 and 20,611																																																			47,050,000
commitments and contingencies—note 10
patient accounts receivable, net of allowance for doubtful accounts of 20,447, and 17,438																																																				163,461,000
property and equipment, net of accumulated depreciation of 105,157 and 94,266																																																				150,947,000
intangible assets, net of accumulated amortization of 22,745 and 20,611																																																				51,959,000
patient accounts receivable, net of allowance for doubtful accounts of 19,603, and 17,438																																																					163,161,000
property and equipment, net of accumulated depreciation of 96,891 and 94,266																																																					146,207,000
intangible assets, net of accumulated amortization of 22,024 and 20,611																																																					49,335,000
commitments and contingencies - note 7
patient accounts receivable, net of allowance for doubtful accounts of 17,438, and 20,977																																																						148,061,000
property and equipment, net of accumulated depreciation of 94,266, and 78,074																																																						148,536,000
intangible assets, net of accumulated amortization of 20,611 and 17,135																																																						50,067,000
patient accounts receivable, net of allowance for doubtful accounts of 18,110 and 20,977																																																							151,208,000
property and equipment, net of accumulated depreciation of 85,351 and 78,074																																																							146,928,000
intangible assets, net of accumulated amortization of 19,875 and 17,135																																																							52,259,000
total amedisys, inc. stockholders' equity																																																							510,574,000										597,294,000
patient accounts receivable, net of allowance for doubtful accounts of 18,162 and 20,977																																																								153,273,000
property and equipment, net of accumulated depreciation of 77,832 and 78,074																																																								144,446,000
intangible assets, net of accumulated amortization of 19,130 and 17,135																																																								62,331,000
patient accounts receivable, net of allowance for doubtful accounts of 19,125 and 20,977																																																									141,923,000
property and equipment, net of accumulated depreciation of 81,300 and 78,074																																																									144,023,000
intangible assets, net of accumulated amortization of 18,280 and 17,135																																																									52,248,000
patient accounts receivable, net of allowance for doubtful accounts of 20,977 and 26,371																																																										141,549,000
property and equipment, net of accumulated depreciation of 78,074 and 59,780																																																										138,554,000
intangible assets, net of accumulated amortization of 17,135 and 11,826																																																										53,393,000
obligations due medicare																																																										4,618,000	4,618,000	4,618,000	4,618,000	4,618,000	4,618,000	4,618,000	4,631,000	4,631,000	4,631,000	4,631,000	3,185,000	2,811,000	2,811,000	5,927,000	5,927,000	6,139,000	6,139,000	7,873,000	10,546,000	10,551,000
commitments and contingencies—note 9
patient accounts receivable, net of allowance for doubtful accounts of 23,036 and 26,371																																																											136,450,000
property and equipment, net of accumulated depreciation of 75,954 and 59,780																																																											117,820,000
intangible assets, net of accumulated amortization of 15,972 and 11,826																																																											55,900,000
patient accounts receivable, net of allowance for doubtful accounts of 24,523 and 26,371																																																												151,855,000
property and equipment, net of accumulated depreciation of 71,790 and 59,780																																																												112,143,000
intangible assets, net of accumulated amortization of 14,792 and 11,824																																																												57,732,000
patient accounts receivable, net of allowance for doubtful accounts of 25,806 and 26,371																																																													150,572,000
property and equipment, net of accumulated depreciation of 65,658 and 59,780																																																													95,440,000
intangible assets, net of accumulated amortization of 13,337 and 11,824																																																													59,093,000
patient accounts receivable, net of allowance for doubtful accounts of 26,371 and 27,052																																																														150,269,000
property and equipment, net of accumulated depreciation of 59,780 and 39,208																																																														91,919,000
intangible assets, net of accumulated amortization of 11,824 and 7,944																																																														57,608,000
commitments and contingencies — note 9
patient accounts receivable, net of allowance for doubtful accounts of 28,352 and 27,052																																																															141,011,000
property and equipment, net of accumulated depreciation of 54,192 and 39,208																																																															87,021,000
intangible assets, net of accumulated amortization of 10,648 and 7,944																																																															57,361,000
accumulated other comprehensive loss																																																															-36,000	-181,000	-469,000						-3,000
patient accounts receivable, net of allowance for doubtful accounts of 30,806 and 27,052																																																																154,279,000
property and equipment, net of accumulated depreciation of 48,326 and 39,208																																																																82,644,000
intangible assets, net of accumulated amortization of 9,487 and 7,944																																																																57,332,000
patient accounts receivable, net of allowance for doubtful accounts of 28,732 and 27,052																																																																	154,368,000
property and equipment, net of accumulated depreciation of 43,828 and 39,208																																																																	80,740,000
intangible assets, net of accumulated amortization of 8,526 and 7,944																																																																	50,791,000
patient accounts receivable, net of allowance for doubtful accounts of 27,052 and 12,968																																																																		175,698,000
property and equipment, net of accumulated depreciation of 39,208 and 24,766																																																																		79,258,000
intangible assets, net of accumulated amortization of 7,944 and 6,261																																																																		42,388,000
liabilities and stockholders’ equity
minority interests																																																																		783,000	778,000	807,000	805,000	849,000	831,000
stockholders’ equity:
total stockholders’ equity																																																																		561,335,000	528,288,000	495,958,000	468,433,000	446,971,000	424,147,000	399,443,000	379,983,000	364,007,000	231,754,000	215,860,000	202,936,000	192,599,000	182,446,000	169,570,000	158,798,000	148,473,000	140,990,000	64,096,000	57,580	51,399	25,376	21,139		16,963
total liabilities and stockholders’ equity																																																																		1,070,194,000	1,050,723,000	1,022,450,000	1,037,747,000	587,111,000	564,727,000	518,671,000	483,115,000	463,756,000	370,188,000	347,680,000	339,511,000	339,997,000	330,605,000	232,919,000	217,726,000	199,733,000	187,914,000	111,015,000	106,128	92,473	67,688	60,069		58,324
patient accounts receivable, net of allowance for doubtful accounts of 19,967 and 12,968 at september 30, 2008 and december 31, 2007, respectively																																																																			179,768,000
property and equipment, net of accumulated depreciation of 34,920 and 24,766 at september 30, 2008 and december 31, 2007, respectively																																																																			80,387,000
intangible assets, net of accumulated amortization of 7,700 and 6,261 at september 30, 2008 and december 31, 2007, respectively																																																																			44,480,000
patient accounts receivable, net of allowance for doubtful accounts of 15,957 and 12,968 at june 30, 2008 and december 31, 2007, respectively																																																																				161,864,000
property and equipment																																																																				78,504,000	75,397,000	68,313,000	66,709,000	66,896,000	55,401,000	52,960,000	42,857,000	36,700,000	30,282,000	27,389,000	24,315,000	19,825,000	14,677,000	10,003,000	9,127,000	8,121,000	7,239	7,219	6,919	7,378	7,815	8,257
intangible assets																																																																				44,608,000	27,888,000	14,301,000	13,891,000	13,661,000	12,741,000		12,837,000
patient accounts receivable, net of allowance for doubtful accounts of 17,643 and 12,968 at march 31, 2008 and december 31, 2007, respectively																																																																					144,066,000
long-term obligations, less current portions																																																																									2,555,000		36,513,000	39,217,000	41,151,000
patient accounts receivable, net of allowance for doubtful accounts of 9,870 and 12,387 at december 31, 2006 and 2005, respectively																																																																										74,929,000
intangible assets, net of accumulated amortization of 4,899 and 3,108 at december 31, 2006 and 2005, respectively																																																																										12,733,000
unearned compensation																																																																														-628,000	-755,000	-663,000	-449,000
preferred stock, .001 par value, 5,000,000 shares authorized; none issued and outstanding
patient accounts receivable, net of allowance for doubtful accounts of 7,626 at june 30, 2006 and 12,387 at december 31, 2005																																																																												63,814,000
intangible assets, net of accumulated amortization of 4,169 at june 30, 2006 and 3,108 at december 31, 2005																																																																												14,199,000
patient accounts receivable, net of allowance for doubtful accounts of 10,615 at march 31, 2006 and 12,387 at december 31, 2005																																																																													67,402,000
intangible assets, net of accumulated amortization of 3,722 march 31, 2006 and 3,108 at december 31, 2005																																																																													11,417,000
short-term revolving line of credit																																																																													10,000,000
short-term investments
patient accounts receivable, net of allowance for doubtful accounts of 12,387 and 3,751 at december 31, 2005 and 2004																																																																														68,139,000
intangible assets, net of accumulated amortization at december 31, 2005 of 3,108 and 1,177 at december 31, 2004																																																																														11,447,000
current portion of long term obligations																																																																														10,144,000
long-term obligations																																																																														43,063,000
other long-term liabilities																																																																														824,000	826,000	826,000	826,000	826,000	826,000	1,213,000	1,213	1,213	1,212	826	826	827
preferred stock, .001 par value, 5,000,000 shares authorized; none issued or outstanding
assets:
patient accounts receivable, net of allowance for doubtful accounts of 11,270 at september 30, 2005 and 3,751 at december 31, 2004																																																																															59,212,000
inventory and other current assets																																																																															5,827,000	3,230,000	2,838,000	3,377,000	1,238,000	1,123,000	1,269	1,879	955	722	1,092	857
intangible assets, net of accumulated amortization of 2,756 at september 30, 2005 and 1,177 at december 31, 2004																																																																															13,981,000
liabilities and stockholders’ equity:
accrued expenses:
payroll and payroll taxes																																																																															27,887,000	19,924,000	14,920,000	11,914,000	12,650,000	13,536,000	10,639	9,163	8,755	7,394	6,437	6,504
insurance																																																																															9,539,000	5,325,000	5,438,000	4,663,000	2,725,000	2,908,000	1,990	2,336	2,265	2,309	2,112	2,171
income taxes																																																																															4,957,000	1,359,000	2,619,000	271,000	837,000	1,400,000	735	575	641	457	458	297
legal settlements																																																																															1,739,000	1,950,000	2,013,000		1,375,000	1,367,000	1,337	1,248	1,292	2,035	2,181	1,887
other																																																																															11,716,000	5,713,000	4,955,000	3,822,000	3,806,000	3,919,000	7,985	2,818	3,491	3,148	2,435	2,439
current portion of long-term debt																																																																															9,301,000	3,433,000	3,396,000	1,689,000	3,871,000	3,875,000	4,175	3,974	3,970	3,615	3,970	3,903
current portion of obligations under capital leases																																																																															223,000	228,000	250,000	423,000	435,000	456,000	653	1,217	1,773	2,274	2,561	2,476
current portion of medicare liabilities																																																																															11,583,000	9,119,000		9,327,000		9,326,000	9,350	9,347	8,433	7,795	8,617	8,948
long-term debt																																																																															55,072,000	1,928,000	2,066,000	1,380,000		921,000	1,807	2,696	2,829	2,879	3,674	4,474
obligations under capital leases																																																																															136,000	162,000	189,000	329,000	401,000	486,000	391	391	396	334	534	1,042
patient accounts receivable, net of allowance for doubtful accounts of 4,943 at june 30, 2005 and 3,751 at december 31, 2004																																																																																36,994,000
intangible assets, net of accumulated amortization of 1,982 at june 30, 2005 and 1,177 at december 31, 2004																																																																																7,032,000
patient accounts receivable, net of allowance for doubtful accounts of 4,216 at march 31, 2005 and 3,751 at december 31, 2004																																																																																	24,848,000
intangible assets, net of accumulated amortization of 1,549 at march 31, 2005 and 1,177 at december 31, 2004																																																																																	6,621,000
medicare liabilities																																																																																	9,263,000		9,358,000
patient accounts receivable, net of allowance for doubtful accounts of 3,751 and 3,008 at december 31, 2004 and 2003																																																																																		24,478,000
intangible assets, net of 1,177 net of accumulated amortization at december 31, 2004																																																																																		4,447,000
legal and other settlements																																																																																		1,833,000
patient accounts receivable, net of allowance for doubtful accounts of 3,249 at september 30, 2004 and 3,008 at december 31, 2003																																																																																			18,265,000
goodwill and other assets																																																																																			63,565,000	57,383,000	55,106	35,658				25,768
long-term debt, net of current portion																																																																																			1,657,000
patient accounts receivable, net of allowance for doubtful accounts of 3,624 at june 30, 2004 and 3,008 at december 31, 2003																																																																																				19,841,000
patient accounts receivable, net of allowance for doubtful accounts
of 3,554 at march 31, 2004 and 3,008 at december 31, 2003																																																																																					14,893
preferred stock, .001 par value, 5,000,000 shares authorized;
none issued and outstanding
12,146,898 and 11,908,146 shares issued at march 31, 2004 and december 31, 2003, respectively																																																																																					12
patient accounts receivable, net of allowance for doubtful accounts of 3,008 and 1,865 at december 2003 and 2002																																																																																						15,185
long-term medicare liabilities																																																																																							3,078	3,444	3,328	3,898
accumulated deficit																																																																																						-4,053	-7,416	-9,797
patient accounts receivable, net of allowance for doubtful accounts of 2,641 at september 30, 2003 and 1,865 at december 31, 2002																																																																																							11,567
patient accounts receivable, net of allowance for doubtful accounts of 2,192 at june 30, 2003 and 1,865 at december 31, 2002																																																																																								9,424
preferred stock, .001 par value, 5,000,000 shares authorized; none outstanding
patient accounts receivable, net of allowance for doubtful accounts of 2,309 in march 2003 and 1,865 in december 2002																																																																																									10,227
stockholder’s equity:
common stock .001 par value, 30,000,000 shares authorized;																																																																																									9
total stockholder’s equity																																																																																									19,097
total liabilities and stockholder’s equity																																																																																									58,006
patient accounts receivable, net of allowance for doubtful accounts of 1,865 and 3,125 at december 2002 and 2001																																																																																										13,467
notes payable
minority interest in consolidated subsidiaries

We provide you with 20 years of balance sheets for Amedisys stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Amedisys. Explore the full financial landscape of Amedisys stock with our expertly curated balance sheets.

The information provided in this report about Amedisys stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.